BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 57 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $268,344 | -27.2% | 258,023 | -10.4% | 0.00% | – |
| Q2 2023 | $368,500 | -3.4% | 287,891 | +4.9% | 0.00% | – |
| Q1 2023 | $381,457 | +7.4% | 274,430 | +0.5% | 0.00% | – |
| Q4 2022 | $355,047 | -46.0% | 273,113 | -38.4% | 0.00% | – |
| Q3 2022 | $657,000 | -28.4% | 443,196 | -1.6% | 0.00% | – |
| Q2 2022 | $918,000 | -79.2% | 450,331 | -72.1% | 0.00% | – |
| Q1 2022 | $4,418,000 | -45.3% | 1,612,389 | -2.2% | 0.00% | – |
| Q4 2021 | $8,079,000 | -56.1% | 1,648,693 | +13.3% | 0.00% | -100.0% |
| Q3 2021 | $18,401,000 | +26.4% | 1,454,527 | +54.4% | 0.00% | – |
| Q2 2021 | $14,561,000 | -47.3% | 941,850 | +12.2% | 0.00% | -100.0% |
| Q1 2021 | $27,617,000 | – | 839,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |